Business Description
Genomic Vision SA
ISIN : FR0011799907
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -0.7 | |||||
Debt-to-Equity | -0.35 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -5.67 | |||||
Beneish M-Score | -5.18 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -48.2 | |||||
3-Year EBITDA Growth Rate | 33.2 | |||||
3-Year EPS without NRI Growth Rate | 12.1 | |||||
3-Year FCF Growth Rate | 43.3 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.41 | |||||
Quick Ratio | 0.36 | |||||
Days Inventory | 1900.96 | |||||
Days Sales Outstanding | 92.52 | |||||
Days Payable | 3377.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -34.1 | |||||
Shareholder Yield % | -73.96 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 88.38 | |||||
Operating Margin % | -571.87 | |||||
Net Margin % | -682.21 | |||||
FCF Margin % | -352.47 | |||||
ROE % | -762.49 | |||||
ROA % | -232.34 | |||||
ROIC % | -235.22 | |||||
3-Year ROIIC % | 1423.13 | |||||
ROC (Joel Greenblatt) % | -770.72 | |||||
ROCE % | -2160.69 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.09 | |||||
EV-to-EBIT | -0.19 | |||||
EV-to-EBITDA | -0.22 | |||||
EV-to-Revenue | 1.07 | |||||
EV-to-FCF | -0.3 | |||||
Earnings Yield (Greenblatt) % | -526.32 | |||||
FCF Yield % | -791.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Genomic Vision SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.557 | ||
EPS (TTM) (€) | -0.097 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 0.45142 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 0.45142 - 0.45142 | ||
Shares Outstanding (Mil) | 385.11 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genomic Vision SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genomic Vision SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Genomic Vision SA Frequently Asked Questions
What is Genomic Vision SA(LTS:0QT4)'s stock price today?
When is next earnings date of Genomic Vision SA(LTS:0QT4)?
Does Genomic Vision SA(LTS:0QT4) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |